Form 8-K - Current report:
SEC Accession No. 0001599901-24-000184
Filing Date
2024-11-07
Accepted
2024-11-07 16:09:39
Documents
15
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-20241107.htm   iXBRL 8-K 26144
2 EX-99.1 rna-2024117xexx991.htm EX-99.1 77018
6 gfnzizaxnpmk000001a.jpg GRAPHIC 206622
  Complete submission text file 0001599901-24-000184.txt   489411

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20241107.xsd EX-101.SCH 1812
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20241107_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20241107_pre.xml EX-101.PRE 13067
17 EXTRACTED XBRL INSTANCE DOCUMENT rna-20241107_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 241435692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)